Repligen | RGEN - Net Income


Repligen reported $13.29M in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
Agilent USD 305M 129M Dec/2025
Align Technology USD 135.76M 79.01M Dec/2025
Bio Techne USD 38.01M 176K Dec/2025
BioMarin Pharmaceutical USD -46.57M 15.83M Dec/2025
Bristol-Myers Squibb USD 1.09B 1.11B Dec/2025
Bruker USD 26M 88.4M Dec/2025
Charles River Laboratories USD -276.56M 330.98M Dec/2025
Danaher USD 1.03B 168M Mar/2026
Dentsply International USD -146M 281M Dec/2025
General Electric Aerospace USD 1.9B 637M Mar/2026
Henry Schein USD 101M 0 Dec/2025
Illumina USD 334M 184M Dec/2025
IQVIA Holdings USD 514M 183M Dec/2025
Mettler Toledo International USD 285.76M 68.27M Dec/2025
Myriad Genetics USD -7.9M 19.5M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Pacific Biosciences Of California USD -40.37M 2.37M Dec/2025
Pfizer USD -1.65B 5.19B Dec/2025
Repligen USD 13.29M 1.62M Dec/2025
Revvity USD 98.36M 51.71M Dec/2025
Standard Biotools USD 19.28M 53.97M Dec/2025
Thermo Fisher Scientific USD 1.65B 313M Mar/2026
Waters USD 225.21M 76.29M Dec/2025
West Pharmaceutical Services USD 138.8M 6.7M Mar/2026